Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants
- 1 October 2011
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 115 (4), 827-834
- https://doi.org/10.3171/2011.5.jns101929
Abstract
The aim of this study was to determine whether patients with neurofibromatosis Type 2 (NF2) who have intact ipsilateral cochlear nerves can have open-set speech discrimination following cochlear implantation. Records of 7 patients with documented NF2 were reviewed to determine speech discrimination outcomes following cochlear implantation. Outcomes were measured using consonant-nucleus-consonant words and phonemes; Hearing in Noise Test sentences in quiet; and City University of New York sentences in quiet and in noise. Preoperatively, none of the patients had open-set speech discrimination. Five of the 7 patients had previously undergone excision of ipsilateral vestibular schwannoma (VS). One of the patients who received a cochlear implant had received radiation therapy for ipsilateral VS, and another was undergoing observation for a small ipsilateral VS. Following cochlear implantation, 4 of 7 patients with NF2 had open-set speech discrimination following cochlear implantation during extended follow-up (15–120 months). Two of the 3 patients without open-set speech understanding had a prolonged period between ipsilateral VS resection and cochlear implantation (120 and 132 months), and had cochlear ossification at the time of implantation. The other patient without open-set speech understanding had good contralateral hearing at the time of cochlear implantation. Despite these findings, 6 of the 7 patients were daily users of their cochlear implants, and the seventh is an occasional user, indicating that all of the patients subjectively gained some benefit from their implants. Cochlear implantation can provide long-term auditory rehabilitation, with open-set speech discrimination for patients with NF2 who have intact ipsilateral cochlear nerves. Factors that can affect implant performance include the following: 1) a prolonged time between VS resection and implantation; and 2) cochlear ossification.Keywords
This publication has 38 references indexed in Scilit:
- Neurofibromatosis type 2 (NF2): A clinical and molecular reviewOrphanet Journal of Rare Diseases, 2009
- Auditory rehabilitation with cochlear implantation in patients with neurofibromatosis type 2Acta Oto-Laryngologica, 2009
- Hearing Rehabilitation in Neurofibromatosis Type 2 Patients: Cochlear versus Auditory Brainstem ImplantationAudiology and Neurotology, 2008
- CNAP To Predict Functional Cochlear Nerve Preservation in NF-2: Cochlear Implant or Auditory Brainstem ImplantJournal of Neurological Surgery Part B: Skull Base, 2008
- Cochlear implantation after translabyrinthine acoustic tumour removal: preliminary resultsCochlear Implants International, 2005
- Simultaneous Cochlear Implantation and Translabyrinthine Removal of Vestibular Schwannoma in an Only Hearing Ear: Report of Two Cases (Neurofibromatosis Type 2 and Unilateral Vestibular Schwannoma)Otology & Neurotology, 2005
- Auditory Brainstem Implantation in Patients with Neurofibromatosis Type 2The Laryngoscope, 2004
- Cochlear Implantation after Acoustic Tumour Resection in Neurofibromatosis Type 2: Impact of Intra- and Postoperative Neural Response Telemetry MonitoringORL, 2003
- Cochlear Implantation Concurrent With Translabyrinthine Acoustic Neuroma ResectionThe Laryngoscope, 2003
- Cochlear implantation in an intralabyrinthine acoustic neuroma patient after resection of an intracanalicular tumourThe Journal of Laryngology & Otology, 1996